The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,610.00
Bid: 1,612.00
Ask: 1,614.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.124%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,610.00
SCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Non-Executive Director

22 Mar 2022 07:00

RNS Number : 5212F
Softcat PLC
22 March 2022
 

22 March 2022

 

Softcat plc

 

Appointment of Non-Executive Director

 

 

Softcat plc ("Softcat" or the "Company"), a leading UK provider of IT infrastructure technology and services, is pleased to announce the appointment of Lynne Weedall as an independent non-executive Director of the Company.

 

Lynne brings significant experience to add to the Board of Softcat through a number of prior senior positions in Human Resources. Previous senior executive positions include Group People & Culture Director of Selfridges Group, and Group Human Resources & Strategy Director of Carphone Warehouse.

 

Since leaving Selfridges, Lynne has taken on non-executive director roles at Dr. Martens plc, Stagecoach Group plc and Treatt plc. She is chair of the remuneration committee at Dr. Martens plc and Stagecoach Group plc and the senior independent director at Dr. Martens plc and Treatt plc. Previous non-executive roles include William Hill plc and Greene King plc.

 

It is intended that Lynne's appointment will become effective from 3 May 2022. She will serve as Chair of the Board's Remuneration Committee, taking over from Karen Slatford who will continue as senior independent Director and Chair of the Nomination Committee.

 

Commenting on the appointment, Martin Hellawell, non-executive Chairman of Softcat said:

 

"The Board has previously discussed the potential benefits of adding a further non-executive Director, if that person would add further significant value to the Board's effectiveness, skillset and expertise and would be a good fit. Lynne certainly meets all these requirements as well as rebalancing the workload of some of our other non-executive Directors. I am delighted that she has agreed to join our Board.

 

Her insights from her executive career together with the significant experience gained on the boards of listed companies will further strengthen our Board. All of us at Softcat look forward to working with her and taking advantage of her insights as we push ahead with our proven strategy for growth.

 

I would like to thank Karen Slatford for chairing the Remuneration Committee so professionally and effectively since her appointment in 2019 and look forward to continuing to work closely with her in her Board roles at Softcat."

 

 

For further information, please contact:

Softcat plc

Graeme Watt, Chief Executive Officer

+44 (0)1628 403 610

Graham Charlton, Chief Financial Officer

Media Enquiries FTI Consulting LLP

Ed Bridges/Matt Dixon

+44 (0)20 3727 1000

 

 

 

Other information

The following details are required to be disclosed under 9.6.13R of the Listing Rules of the Financial Conduct Authority in respect of other directorships held by Lynne Weedall in a publicly quoted company at any time in the previous five years:

 

· 11 January 2021 - current. Dr. Martens plc: senior independent Director and Chair, Remuneration Committee.

· 1 August 2020 - current. Stagecoach Group plc: Non-executive Director and Chair, Remuneration Committee.

· 6 April 2019 - current. Treatt plc: Senior Independent Director and Chair, Nominations Committee.

· 1 July 2019 - 22 April 2021. William Hill plc: Non-executive Director & Chair, Remuneration Committee.

· 11 October 2012 - 30 October 2019. Greene King plc: Non-executive Director and Chair, Remuneration Committee.

 

 

Governance considerations and consequent Board composition

The Nomination Committee of Softcat worked with an external search firm on this appointment. The search firm provided a list of highly experienced candidates for the role, which included Lynne Weedall and each candidate was reviewed or interviewed by the Committee. Lynne stood out as the best candidate to further enhance the Board.

 

Since January 2021, Lynne and Softcat non-executive Director Robyn Perriss have both served as independent non-executive Directors of Dr. Martens plc, a UK listed company. However, they are not involved in executive duties for Dr. Martens plc and each have a similar obligation to be independent for Dr. Martens plc as they do for Softcat. Consequently, the Board of Softcat does not consider that their position as independent non-executive Directors of the Company are adversely impacted by their roles on the board of Dr. Martens plc. The Board of Softcat is satisfied that they are both to be regarded as independent under the 2018 UK Corporate Governance Code.

 

Following Lynne Weedall's appointment, the composition of the Board will be:

 

Non-executive Directors:

· Martin Hellawell - Chair

· Karen Slatford - Chair of the Nomination Committee and senior independent Director

· Lynne Weedall - Chair of the Remuneration Committee

· Robyn Perriss - Chair of the Audit Committee

· Vin Murria - Designated Director for Workforce Engagement

 

 

Executive Directors:

· Graeme Watt - CEO

· Graham Charlton - CFO

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUUAWUPPGBG
Date   Source Headline
1st May 202410:50 amRNSTotal Voting Rights
9th Apr 20249:45 amRNSDirector/PDMR Shareholding
2nd Apr 20249:13 amRNSTotal Voting Rights
26th Mar 20241:00 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSHalf-year Report
15th Mar 20242:45 pmRNSDirector/PDMR Shareholding
4th Mar 20247:00 amRNSNotice of Results
1st Mar 20242:28 pmRNSHolding(s) in Company
1st Mar 202410:47 amRNSTotal Voting Rights
8th Feb 20249:34 amRNSDirector/PDMR Shareholding
1st Feb 20249:49 amRNSTotal Voting Rights
30th Jan 20249:58 amRNSHolding(s) in Company
9th Jan 20243:48 pmRNSDirector/PDMR Shareholding
9th Jan 202412:42 pmRNSHolding(s) in Company
2nd Jan 20249:50 amRNSTotal Voting Rights
18th Dec 20239:58 amRNSBlock listing Interim Review
14th Dec 202311:29 amRNSDirector/PDMR Shareholding
14th Dec 202311:25 amRNSResult of AGM
12th Dec 20234:20 pmRNSDirector/PDMR Shareholding
8th Dec 20231:02 pmRNSDirector/PDMR Shareholding
1st Dec 20233:58 pmRNSTotal Voting Rights
28th Nov 20237:00 amRNSQ1 2024 Trading Update
24th Nov 20234:54 pmRNSDirector/PDMR Shareholding
24th Nov 20234:51 pmRNSDirector/PDMR Shareholding
8th Nov 20233:22 pmRNSDirector/PDMR Shareholding
1st Nov 202310:08 amRNSAnnual Financial Report and Notice of AGM
24th Oct 20237:00 amRNSFinal Results
10th Oct 202310:40 amRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNSNotice of Results
2nd Oct 202310:38 amRNSTotal Voting Rights
8th Sep 20232:32 pmRNSDirector/PDMR Shareholding
1st Sep 202310:04 amRNSTotal Voting Rights
10th Aug 202310:59 amRNSDirector/PDMR Shareholding
1st Aug 202312:22 pmRNSTotal Voting Rights
1st Aug 20237:00 amRNSAppointment of Non-Executive Directors
10th Jul 20232:10 pmRNSDirector/PDMR Shareholding
3rd Jul 20239:19 amRNSTotal Voting Rights
8th Jun 202311:23 amRNSDirector/PDMR Shareholding
1st Jun 202312:32 pmRNSTotal Voting Rights
1st Jun 202311:08 amRNSBlock listing Interim Review
30th May 20237:00 amRNSQ3 2023 Trading Update
25th May 20238:47 amRNSDirector Declaration
10th May 20238:59 amRNSDirector/PDMR Shareholding
2nd May 20235:08 pmRNSTotal Voting Rights
12th Apr 202310:14 amRNSDirector/PDMR Shareholding
3rd Apr 20239:34 amRNSTotal Voting Rights
28th Mar 20237:00 amRNSHalf-year Report
16th Mar 20232:39 pmRNSConfirmation of CFO Appointment Date
15th Mar 20237:00 amRNSNotice of Results
9th Mar 20232:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.